- Home
- BGI vs CING Comparison
BGI vs CING Comparison
Compare BGI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGI
- CING
- Stock Information
- Founded
- BGI 1879
- CING 2012
- Country
- BGI Canada
- CING United States
- Employees
- BGI N/A
- CING N/A
- Industry
- BGI
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- BGI
- CING Health Care
- Exchange
- BGI Nasdaq
- CING Nasdaq
- Market Cap
- BGI 22.7M
- CING 21.6M
- IPO Year
- BGI 2005
- CING 2021
- Fundamental
- Price
- BGI $1.09
- CING $3.35
- Analyst Decision
- BGI
- CING Strong Buy
- Analyst Count
- BGI 0
- CING 4
- Target Price
- BGI N/A
- CING $33.00
- AVG Volume (30 Days)
- BGI 35.8K
- CING 203.7K
- Earning Date
- BGI 11-28-2025
- CING 11-13-2025
- Dividend Yield
- BGI N/A
- CING N/A
- EPS Growth
- BGI N/A
- CING N/A
- EPS
- BGI N/A
- CING N/A
- Revenue
- BGI $124,446,731.00
- CING N/A
- Revenue This Year
- BGI N/A
- CING N/A
- Revenue Next Year
- BGI N/A
- CING N/A
- P/E Ratio
- BGI N/A
- CING N/A
- Revenue Growth
- BGI N/A
- CING N/A
- 52 Week Low
- BGI $0.56
- CING $3.21
- 52 Week High
- BGI $2.03
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- BGI 45.49
- CING 39.26
- Support Level
- BGI $1.13
- CING $3.22
- Resistance Level
- BGI $1.14
- CING $3.81
- Average True Range (ATR)
- BGI 0.04
- CING 0.23
- MACD
- BGI -0.01
- CING -0.03
- Stochastic Oscillator
- BGI 16.00
- CING 18.44
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.